 |
Journal of General
Virology |
| First posted
online 7 December 2001 |
ARTICLE ABSTRACT |
| Rec 19 July 2001; Acc 26 November
2001 |
DOI:
10.1099/vir.0.17982-0 |
In vitro and in vivo
expression of foreign genes by transmissible gastroenteritis
coronavirus-derived minigenomes
Sara Alonso,1 Isabel
Sola,1 Jens P. Teifke,2 Ilona Reimann,2
Ander Izeta,1 Mónica Balasch,3 Juan
Plana-Durán,3 Rob J. M. Moormann4 and Luis
Enjuanes1
1 Department of Molecular and
Cell Biology, Centro Nacional de Biotecnología, CSIC, Campus
Universidad Autónoma, Cantoblanco, 28049 Madrid, Spain
2 Federal Research Centre for Virus Diseases of Animals,
Friedrich-Loeffler-Institutes, Insel Riems, Germany
3 Fort Dodge Veterinaria, Girona, Spain
4 Institute for Animal Science and Health, Lelystad, The
Netherlands
A
helper-dependent expression system based on
transmissible gastroenteritis coronavirus (TGEV) has been developed using
a minigenome of 3.9 kb (M39). Expression of the reporter gene
-glucuronidase (GUS) (28 µg per
106
cells) and the porcine respiratory and reproductive syndrome virus (PRRSV)
ORF5 (12 µg per 106 cells) has been shown using a
TGEV-derived minigenome. GUS expression levels increased about eightfold
with the m.o.i. and were maintained for more than eight passages in cell
culture. Nevertheless, instability of the GUS and ORF5 subgenomic mRNAs was observed
from passages five and four, respectively. About a quarter of the cells in culture expressing the
helper virus also produced the reporter gene as determined by studying GUS
mRNA production by in situ hybridization or immunodetection to
visualize the protein synthesized. Expression of GUS was detected in the
lungs, but not in the gut, of swine immunized with the virus vector.
Around a quarter of lung cells showing replication of the helper virus
were also positive for the reporter gene. Interestingly, strong humoral
immune responses to both GUS and PRRSV ORF5 were induced in swine with
this virus vector. The large cloning capacity and the tissue specificity
of the TGEV-derived minigenomes suggest that these virus vectors are very
promising for vaccine development.
Click here for full text HTML
JGV Direct table of contents
© 2002 SGM
This article is now available in the March
2002 print issue of JGV (vol. 83, 567579).
The complete issue of the journal may be seen in electronic form on JGV
Online.